Subgroups of primary Sjögren’s syndrome. Sjögren’s syndrome in male and paediatric Greek patients
OBJECTIVES To describe the clinical and serological findings in male and paediatric Sjögren’s syndrome (SS) patients. PATIENTS AND METHODS Using the European criteria for the diagnosis of SS 12 male and 13 paediatric patients were identified and compared with those of 30 consecutive unselected adult...
Saved in:
Published in | Annals of the rheumatic diseases Vol. 56; no. 5; pp. 333 - 335 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
London
BMJ Publishing Group Ltd and European League Against Rheumatism
01.05.1997
BMJ BMJ Publishing Group LTD |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | OBJECTIVES To describe the clinical and serological findings in male and paediatric Sjögren’s syndrome (SS) patients. PATIENTS AND METHODS Using the European criteria for the diagnosis of SS 12 male and 13 paediatric patients were identified and compared with those of 30 consecutive unselected adult female SS patients. RESULTS The mean (SD) age of paediatric patients was 9.4 (2.2) years, ranging from 6 to 14 years. Recurrent parotid gland enlargement was the initial clinical manifestation in the majority of the children with a statistical significance compared with male (p<0.01) and with female patients (p<0.0001). Sicca manifestations were the most common clinical symptoms in male and female patients at disease onset. The systemic manifestations were similar among the three groups except that men showed lower frequency of arthritis (p<0.05) and Raynaud’s phenomenon (p<0.05) compared with women. No differences were found among the immunological profile of children and female patients, while male patients had a lower frequency of antinuclear antibodies (p<0.025) and antibodies to Ro(SSA) nuclear antigens (p<0.025) compared with women. CONCLUSION Primary SS is rare in children and men in Greece. Recurrent parotid gland enlargement is the most common clinical finding at disease onset in children. Male patients seem to have less systemic manifestations and lower frequency of autoantibodies. |
---|---|
Bibliography: | Dr A A Drosos, Department of Internal Medicine, Medical School,University of Ioannina, 45110 Ioannina, Greece. ark:/67375/NVC-8QP6RFCZ-K local:annrheumdis;56/5/333 istex:56CD33E40C285F16840B3985230A109FA90BDAE8 PMID:9175937 href:annrheumdis-56-333.pdf ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0003-4967 1468-2060 |
DOI: | 10.1136/ard.56.5.333 |